Syndrome of chronic pelvic pain in men: possibilities of diagnostics and treatment


Дәйексөз келтіру

Толық мәтін

Аннотация

The modern classification of prostatitis is presented, it is noted that abacterial chronic prostatitis/chronic pelvic pain syndrome (CPPS) account for 90-95% of cases. The paper is dedicated to the diagnostic criteria for CPPS, the algorithm of assessment, current approaches to the treatment of this disease. The authors present the results of the nutritional supplement Longa-DNA administration, an essential component of which is L-arginine, in 31 patients with CPPS. Following the course of therapy, all patients noted subjective state improvement, mainly manifested in the pain relief.

Әдебиет тізімі

  1. Krieger JN, Ross SO, Riley DE. Chronic prostatitis: epidemiology and role of infection. Urology 2002;60:8-13.
  2. Roberts RO, Lieber MM, Rhodes T, et al. Prevalence of a physicianassigned diagnosis of prostatitis: the Olmsted County Study of urinary symptoms and health status among men. Urology 1998;51:578-84.
  3. Mehik A, Hellstrom P, Lukkarinen O, et al. Epidemiology of prostatitis in Finnish men: a population-based crosssectional study. Br J Urol Int 2000;86:443-48.
  4. McNaughton-Collins M, Stafford RS, O'Leary MP, et al. How common is prostatitis? A national survey of physician visits. J Urol 1998;159:1224-28.
  5. Drach GW, Fair WR, Meares EM, et al. Classification of benign disease associated with prostatic pain: prostatitis or prostatodynia? J Urol 1978;120:266.
  6. Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282:236-37.
  7. Schaeffer AJ, Wendel EF, Dunn JK, et al. Prevalence and significance of prostatic inflammation. J Urol 1981;125:215-19.
  8. Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999;282:236-37.
  9. Krieger JN, Egan KJ, Ross SO, et al. Chronic pelvic pains represent the most prominent urogenital symptoms of "chronic prostatitis." Urology 1996;48:715-22.
  10. Nickel J. Special report on prostatitis: state of the art. Rev Urol 2001;3:94-98.
  11. Litwin MS, McNaughton-Collins M, Fowler FJ, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999;162:369-75.
  12. Nickel JC. Prostatitis and related conditions, in Walsh P, et al (Eds): Campbell's Urology. Philadelphia, WB Saunders Company 2002:603-30.
  13. Nadler RB, Schaeffer AJ. Lower urinary tract cultures, in Nickel JC (Ed): Textbook of Urology. Oxford, ISIS Medical Media 1999:201-06.
  14. Anderson RU: Cytological aspects of diagnosis, in Nickel JC (Ed): Textbook of Urology. Oxford, ISIS Medical Media 1999:207-12.
  15. Nickel JC. Prostatitis: an infectious disease? Infect Urol 2000;13:31-38.
  16. Nickel JC, Alexander RB, Schaeffer AJ, et al. Leukocyte and bacteria localization comparisons in men with chronic prostatitis in asymptomatic men: a case-control study. J Urol 2002;167(Suppl. 4):24, abstr. 96.
  17. Krieger JN, Jacobs R, Ross SO. Detecting urethral and prostatic inflammation in patients with chronic prostatitis. Urology 2000;55:186-91.
  18. Nickel JC. Detecting urethral and prostatic inflammation in patients with chronic prostatitis [editorial comment]. Urology 2000;55:191-92.
  19. Kohn IJ, Te AE, Kaplan SA. The role of urodynamics in evaluating patients with chronic prostatitis, in Nickel JC (Ed): Textbook of Urology. Oxford, ISIS Medical Media 1999:201-06.
  20. De la Rosette JJ, Karthaus HF, Debruyne FM. Ultrasonographic findings in patients with nonbacterial prostatitis. Urol Int 1992;48:323-26.
  21. Letran JL, Brawer MK. Prostate specific antigen in prostatitis, in Nickel JC (Ed): Textbook of Uology. Oxford, ISIS Medical Media 1999:241-45.
  22. Nickel JC. Treatment of chronic prostatitis lowers serum prostate specific antigen [editorial comment]. J Urol 2002;167:1726.
  23. Nickel JC, Downey J, Johnston B, et al: Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial. J Urol 2001;165:1539-44.
  24. Nickel JC, Gittleman M, Malek G, et al. Effect of rofecoxib in patients with chronic nonbacterial prostatitis: a placebo controlled pilot study [abstract]. J Urol 2001;165:27.
  25. Downey J, Nickel JC, Pontari MA, et al. Randomized placebo controlled multi-center pilot study to evaluate the safety and efficacy of finasteride in the treatment of male chronic pelvic pain syndrome: category IIIA CPPS (chronic nonbacterial prostatitis) [abstract]. J Urol 2002;167(Suppl.):26.
  26. Shoskes DA, Zeitlin SI, Shahed A, et al. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54:960-63.
  27. Shoskes D. Use of the bioflavonoid quercetin in patients with long-standing chronic prostatitis. J Am Neutraceut Assoc 1999;2:18-21.
  28. Clemens JQ, Nadler RB, Schaeffer AJ, et al. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology 2000;56:951-55.
  29. Volchegorskii IA, Tarasov NI, Seregin SP. The role of free-radical lipid oxidation in the pathogenesis of chronic prostatitis. Urol Nefrol (Mosk) 1997;(5):24-25.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>